1. Atopic dermatitis (AD) affects 20-25% of pediatric patients and significantly impacts their quality of life.
2. The guidelines emphasize comprehensive skin-directed care and proactive treatment to reduce flare frequency.
3. Racial disparities, mental health implications, and preventive care in atopic dermatitis were highlighted.
4. New treatments, including monoclonal antibodies and Janus kinase inhibitors, expand the therapeutic landscape.
5. Written action plans and equitable care are recommended to improve treatment outcomes.

Source: Pediatrics